Texas Medical Center Institutions Cast Light on Improving Care for Hispanic Patients in Need of Organ Transplants
Houston, Texas (Sept. 13, 2017) – On Tuesday, Sept. 26, 2017 organ donation and transplant professionals will come together to discuss the challenges faced by Texas’ growing population of Hispanic patients with end-stage organ disease during the 2nd Annual Hispanic Transplant Symposium.
LifeGift, Nora’s Home and The Living Bank will co-host the event, designed to be of interest to transplant and dialysis center staff, organ failure patients, transplant patients and members of the community.
“After last year’s inaugural Hispanic Transplant Symposium, the donation and transplantation community realized there is a significant need to continue this type of knowledge and dialogue to best serve this large and growing population,” said Dr. Mark Hobeika, transplant surgeon and chair of this year’s event. “More than 40 percent of those waiting for a lifesaving transplant across Texas identify themselves as Hispanic, which is exactly why this topic needs to remain on the forefront of discussions in the field.”
This year’s keynote speaker is Sylvia E. Rosas, M.D., MSCE, chair of the Minority Affairs Committee at the United Network for Organ Sharing (UNOS.) Rosas, Associate Professor of Medicine at Harvard Medical School, will present solutions proposed by UNOS to help this population. She will also speak on cultural concepts in the Hispanic population that influence health behavior and decisions and how language barriers play a role.
There is no charge to attend the symposium, and continuing education hours will be awarded to nurses, social workers, dieticians and dialysis technicians.
The event will take place at the Bayou City Events Center located at 9401 Knight Road, Houston, Texas 77045.
For more information and to register for free, visit www.lifegift.org/hts.
# # #
About Hispanic Transplant Symposium (HTS)
The Hispanic Transplant Symposium (HTS) is a landmark event convening transplant staff, community partners and those serving the Hispanic community to advance the care of Hispanic patients with end-stage organ disease.